Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Amortizatization of Intangibles (2019 - 2026)

Catheter Precision (VTAK) reported Amortizatization of Intangibles of $28000.0 for Q1 2026, up 21.74% year-over-year from $23000.0 in Q1 2025, and up 21.74% on a QoQ basis from $23000.0 in Q1 2025.

Catheter Precision (VTAK) has 4 years of Amortizatization of Intangibles data on file, last reported at $28000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles rose 21.74% year-over-year to $28000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $251000.0 (down 18.51% YoY) and the FY2019 annual result came in at $330000.0, changed N/A from the prior year.
  • Amortizatization of Intangibles rose to $28000.0 in Q1 2026 per VTAK's latest filing, from $23000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $28000.0 in Q1 2026 and bottomed at $23000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 422.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 180.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 6.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 75.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Catheter Precision 2.01 Mn 1.20 Mn 390,000.00 28,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 28,000.00
Mar 31, 2026 28,000.00
Mar 31, 2025 23,000.00
Mar 31, 2025 23,000.00
Sep 30, 2020 100,000.00
Sep 30, 2020 100,000.00
Jun 30, 2020 100,000.00
Jun 30, 2020 100,000.00
Mar 31, 2020 85,000.00
Mar 31, 2020 85,000.00
Dec 31, 2019 85,000.00
Dec 31, 2019 85,000.00
Sep 30, 2019 100,000.00
Sep 30, 2019 100,000.00
Jun 30, 2019 100,000.00
Jun 30, 2019 100,000.00
Mar 31, 2019 81,000.00
Mar 31, 2019 81,000.00